Infusion Management Services for Infectious Disease Practices

Z21 represents asymptomatic human immunodeficiency virus infection status. It is used when a patient has documented HIV infection without documented symptoms or an HIV-related illness in the coding context. Code selection should reflect the medical record and current coding guidance. Practices should review the full clinical documentation and applicable payer requirements rather than assigning Z21 based on a diagnosis label alone.

B20 identifies human immunodeficiency virus disease, while Z21 identifies asymptomatic HIV infection status. The distinction depends on whether the record documents HIV disease or an asymptomatic infection status. Coding should follow the provider’s documentation, the patient’s clinical circumstances, and current official coding guidance. When related conditions or complications are documented, the complete coding picture may require additional review.

Infusion management can include eligibility and benefits verification, medical-versus-pharmacy benefit review, prior authorization support, drug and administration billing, claims management, denial analysis, payment reconciliation, aging account follow-up, and workflow improvement. For infectious disease practices, the work may also connect with OPAT, specialty drugs, referral processes, documentation, and payer or hospital coverage agreements.

Infusion claims may involve separately evaluated services, drug charges, administration services, authorization requirements, benefit classification, units, NDC information, and payer-specific contract terms. Documentation and charge capture must support the services billed. A practice can therefore experience rejected claims, denials, short-pays, or unrecovered balances when clinical, coding, authorization, and payment workflows are not aligned.

Revenue leakage can be examined by comparing the work performed with documentation, charge capture, submitted claims, payer responses, contract terms, and collected amounts. Useful review areas include under-leveled visits, missing drug or administration charges, authorization gaps, coding issues, short-pays, and aging balances. Reporting by payer, service line, and provider can help connect the financial gap to its operational source.

The service catalog includes eligibility and authorization support for infusions, OPAT courses, and specialty drugs. This includes verifying benefits, determining whether therapy falls under the medical or pharmacy benefit, and managing prior authorization requests. Tracking each request helps the practice maintain visibility into outstanding requirements and reduce the risk of unreimbursed drug costs caused by missing or incomplete authorization.

Denial management includes categorizing denials by root cause, reviewing issues involving drug and administration coding, authorization, benefit classification, and clinical documentation, and preparing payer-specific appeals. Findings can also be shared with clinical, coding, and front-office teams so recurring problems are addressed in the workflow rather than handled only as isolated claim corrections.

A practice can review the full workflow from referral through final payment, including documentation, coding, eligibility, authorization, drug acquisition, infusion billing, claims submission, denials, underpayments, accounts receivable, and coverage agreements. A prioritized review helps distinguish delayed revenue from lost revenue and connects each issue to a practical process change that the practice can evaluate using its own information.